Empiric antimicrobial therapy of serious urinary tract infections.
Parenteral therapy is recommended for empiric treatment of serious urinary tract infections. The approach to antimicrobial selection is reviewed with consideration given to newly available agents.
D000617:Aminoglycosides / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007263:Infusions, Parenteral; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy; D014546:Urinary Catheterization / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins